<DOC>
	<DOCNO>NCT00878540</DOCNO>
	<brief_summary>The purpose study determine metabolic change upon 7 day medication 30 mg mirtazapine per day healthy subject .</brief_summary>
	<brief_title>Short-term Metabolic Effects Mirtazapine Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<criteria>Male sex Age 2025 year Somatically mentally healthy Normal body weight ( body mass index ( BMI ) 18.525 ) Smoking within last 6 month Medication within last 6 month Current former psychiatric illness Positive family history ( first grade relative ) metabolic diseases Alcohol abuse Current former illicit drug abuse Current former drug abuse Known intolerance , former prescription study medication Participation clinical trial time participation clinical trial associate administration drug within last 6 month Homelessness Shift work within last 12 month Known hypersensitivity mirtazapine component drug give Known epilepsy ; glaucoma ; liver , kidney , heart disease ; urinary dysfunction ; hypotonia ; diabetes metabolic disease Known hematologic disease , especially agranulocytosis leukopenia Blood donation within last 6 month prior begin study Hemoglobin 13.5 mg/dL</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>mirtazapine</keyword>
	<keyword>metabolism</keyword>
	<keyword>depression</keyword>
	<keyword>Healthy male</keyword>
</DOC>